Targeting Tumor Metabolism: A Biochemical Explanation Related to A Systems Biology Lipidomics Based Approach

Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells and oncology is a branch of medicine that deals with tumors. This review presents the current state of our knowledge of biomarkers in the selected oncology research area of lipomas (benign) and liposarcomas, (malign). A lipoma is a benign tumor composed of adipose tissue (body fat). It is the most common benign form of soft tissue tumor about 1 in 100 people (1%) will develop a lipoma.

Targeting Tumor Metabolism
Targeting Tumor Metabolism

Numerous case reports document the presence of lipomas in other, rare locations, with these tumors having been found virtually everywhere in the body. Although it has been hypothesized that lipomas may rarely undergo sarcomatous change, this event has never been convincingly documented. It is more probable that lipomas are at the benign end of the spectrum of tumors, which, at the malignant end, include liposarcomas (LS). Liposarcomas are a heterogeneous group of adipocytic tumors that represent approximately 13% of all sarcomas


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s